Skip to main content

Table 1 Baseline Characteristics

From: A retrospective cohort analysis comparing the effectiveness and safety of perioperative angiotensin II to adrenergic vasopressors as a first-line vasopressor in kidney transplant recipients

Variable

AT2S (n=20)

Adrenergic Vasopressors(n=60)

p-value

Age, years

56.3 (10.8)

53.1 (14.6)

0.369

Female Sex, n (%)

11 (55)

9 (45)

0.168

Race/ethnicity, n (%)

   

 -Black

6 (30)

10 (16.7)

0.197

 -White

7 (35)

25 (41.7)

0.598

 -Hispanic

5 (25)

22 (36.7)

0.339

 Height, cm

167.8 (9.6)

169.1 (12.7)

0.67

 Weight, kg

95.1 (24.2)

99.5 (29.3)

0.544

 BMI, kg/m2

33.2 (6.8)

34.9 (10.9)

0.515

Dialysis preoperatively, n (%)

20 (100)

52 (86.7)

0.191

 Time on dialysis, months

86.7 (53.3)

65.7 (36.1)

0.036

Pertinent pre-transplant comorbidities, n (%)

   

 -Hypertension (%)

18 (90)

56 (93.3)

0.624

 -Atrial Fibrillation (%)

 2(10)

5 (8.3)

0.672

 -Coronary Artery Disease (%)

7(35)

15 (25.4)

0.215

 -Diabetes Type II (%)

11(55)

15 (25.4)

0.518

Baseline Systolic BP, mmHg

145.2 (23.6)

157.3 (25.1)

0.063

Baseline Diastolic BP, mmHg

77.4 (13.4)

85.9 (17.3)

0.05

Baseline MAP, mmHg

98.7 (16)

108.1 (17.8)

0.044

Baseline heart rate, bpm

83 (17)

71.5 (9.9)

<0.001

  1. BMI Body mass index, BP Blood pressure, bpm beats per minute, cm centimeter, kg kilogram, MAP Mean arterial pressure, mmHg millimeters of mercury, SCr Serum creatinine
  2. All continuous data presented as means (standard deviation) unless otherwise noted